In conclusion, the high expression of α-SMA, PDPN, PDGFR-β in CAFs led to unfavorable clinical outcomes in breast cancer patients, implicating that all these biomarkers could have potential values in the treatment and prognostic evaluation of breast cancer patients. Here, PDPN is linked to breast cancer.